Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderComplement in the Homeostatic and Ischemic BrainManagement of Postthrombolysis Hemorrhagic and Orolingual Angioedema ComplicationsReview, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptomsIschemic stroke and repair: current trends in research and tissue engineering treatmentsNonhuman primate models of stroke for translational neuroprotection research.The exact science of stroke thrombolysis and the quiet art of patient selectionChallenging comparison of stroke scalesProtective and detrimental effects of neuroectodermal cell–derived tissue factor in mouse models of strokeDiagnosis and management of acute ischemic stroke: speed is criticalThe use of neurovascular imaging for triaging TIA and minor stroke: implications for therapyIn vitro and in vivo high-intensity focused ultrasound thrombolysisThe science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future successCurrent perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeNinety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke.Pitch-catch phase aberration correction of multiple isoplanatic patches for 3-D transcranial ultrasound imaging.High-intensity focused ultrasound (HIFU) for dissolution of clots in a rabbit model of embolic stroke.Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study.Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions.Etiologic subtype predicts outcome in mild stroke: prospective data from a hospital stroke registry.Advanced imaging application for acute ischemic stroke.Magnetic Resonance Imaging in Acute Ischemic Stroke Patients with Mild Symptoms: An Opportunity to Standardize Intravenous ThrombolysisHyperacute imaging of ischemic stroke: role in therapeutic management.Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001.Thrombolysis in acute ischemic stroke: successes, failures, and new hopes.[Thrombolysis for ischemic stroke: an update]Laser therapy in acute stroke treatment.Kids Identifying and Defeating Stroke (KIDS): development and implementation of a multiethnic health education intervention to increase stroke awareness among middle school students and their parentsBeneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.A comprehensive review of prehospital and in-hospital delay times in acute stroke care.Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.Evolution of the thrombolytic treatment window for acute ischemic stroke.Early experience of translating pH-weighted MRI to image human subjects at 3 Tesla.Intravenous tissue plasminogen activator and stroke in the elderlyUtilization of emergency medical service increases chance of thrombolytic therapy in patients with acute ischemic stroke.Thrombolytic Treatment After Acute Ischemic Stroke Results from the Minnesota Stroke Registry and Opportunities to Improve Care.Reasons and evolution of non-thrombolysis in acute ischaemic stroke.MR perfusion imaging in acute ischemic stroke.Patient Selection for Drip and Ship Thrombolysis in Acute Ischemic StrokeUnsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke.
P2860
Q24626017-544525ED-3171-4935-8D1C-7CB252902A3EQ26796057-DA8F60FF-6F9A-4BA7-B1CB-96D2AE1AD337Q26796470-1BCDA4AE-AC81-4F1B-B256-7D3EDC9FD97FQ26825583-8E346861-FCC5-4052-8A54-22888EA9CAF2Q26851602-91C4B668-2378-4429-9FEB-0343EECC0A28Q26859430-D592A0CA-8287-49E6-A0AB-22F5D5CEC448Q27011873-9DC4F757-3C87-4907-9202-E54E5F9745F5Q27026721-BA61502C-9236-4C6C-9261-74B59F2BC09BQ27333861-4468987E-C2FA-4B50-BA16-7024CFAB5DD9Q28085439-923BF597-58BF-49EE-A39E-399ABB9172A1Q28196724-A924A507-78E1-44DF-A58A-5239DEDEBAA8Q28260881-BF860BC7-5F7C-4C7C-857D-436A1255F802Q28394257-92634F4C-F9D7-4B0E-9BBD-27B3DF6BAA22Q30414441-A198C17D-BCE2-4B4C-ABFD-EE7D4225D981Q30422705-D5F35977-6236-4631-BBC8-532F578A0482Q30442309-6577EFC4-CC2C-4BC3-835F-741871A74BFFQ30464947-2335FB5D-D6B4-4097-950B-D9DF34D83CB1Q30501009-75A33D61-CD49-445D-8489-0145EF96DFC4Q30625019-A4C794D9-97B6-4083-954B-32A94C8930CAQ30683526-7F367DA4-4EAF-4D83-8C09-F53E4567ED40Q30950281-C4C385E9-7954-472A-AA8C-163102388D6CQ30956240-A44F0989-F2E4-4A58-AD48-5636EC08CFB5Q30978920-0C515570-8661-4AC9-B21D-C3BBE0D6C525Q31012488-8B4ADF45-9C1B-4B0C-BCA0-46E0E53E2E58Q31023327-B7846F9D-E952-4F57-8AD4-C53B2B9A7245Q31109436-8379B919-57AA-43C1-B10D-06C7FE18D81AQ33360428-CEE4EE26-DB63-40D6-8216-24831777340BQ33563351-33D63684-B36B-4813-A2C1-180D4D1CCAACQ33566724-DF79516E-FDBA-4425-A25B-4920F47E2551Q33671817-A10C3158-473F-41C9-A907-89A164213C4CQ33684081-AEC1CCA6-D510-4A68-9509-2A9410BE1D79Q33688138-FFE8522F-05B2-49DF-92F6-BA294BBC2D7DQ33704792-8BD65B73-8B7F-4E60-9831-E647385D786DQ33724693-54913E2A-F060-4D12-8E34-0EFEA151E9A8Q33801117-0ABBDCFA-456D-48A9-A7AA-913E10B4508BQ33841572-EF095CA6-F519-4AB9-BCA8-42474B283E14Q33886064-6D226DD7-FBF5-472E-BF3F-0B5C9741F816Q33922434-0463A719-31E1-4B07-AB90-263F35CCA82AQ33924623-AA1B8EDC-0AB8-4390-86C8-D798BB5FE6F0Q33942874-FB6B5CEE-663F-4C9C-9FC7-F7B2D23077AF
P2860
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@en
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@nl
type
label
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@en
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@nl
prefLabel
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@en
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@nl
P2093
P356
P1433
P1476
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
@en
P2093
P304
P356
10.1212/WNL.56.8.1015
P407
P577
2001-04-01T00:00:00Z